All Articles

Following a landmark FDA approval and strong earnings, Axsome must convince investors its momentum can translate into long-term profitability and leadership.

A new FDA-cleared shoulder implant from FX Shoulder Solutions offers unprecedented flexibility, allowing surgeons to adapt their approach mid-surgery.

In a market focused on scale, Silvester & Company's acquisition of ChampionScott Partners signals a strategic shift toward specialized, future-focused leadership.

As federal funding for psychedelic therapy surges, practitioners warn that a critical lack of patient preparation and integration support could undermine healing.

HURST Jaws of Life and Elevat launch Captium IQ, an AI-powered system designed to ensure mission-critical rescue equipment is always ready for action.

Three industry titans launch AlphaDrive, a $100M fund blending VC and private equity to back the next generation of Israeli Cyber-AI startups.

AcreTrader's latest deal delivered big returns for investors and let a local family buy the land. Is this a new model for harmony or just a new land rush?

As SandRidge Energy reports Q1 results, investors watch to see if it capitalized on high oil prices while navigating a chaotic natural gas market.

A new platform feature gates content behind social actions like follows, promising creators both audience growth and revenue. But what is the cost to users?

A new alliance of 21 biotech firms aims to forge a national strategy, warning that America's long-held lead in medical innovation is under pressure.

A $33M C-PACE deal for a Deepak Chopra-affiliated resort shows how innovative financing is reshaping real estate development in a tight market.

As consumers seek healthier energy, a new sublingual powder promises a fast, crash-free boost, challenging the dominance of coffee and energy drinks.

CoTec Holdings Corp. joins the OTCQX market, a key step in attracting U.S. investment for its disruptive tech aimed at recycling rare earth magnets.

With its 100th study launch and a perfect client retention rate, Atreo's agile RTSM platform is challenging the rigid, slow pace of traditional trial tech.

A new $50M fund unites venture capital with Canada's top cancer charities, aiming to fast-track lab discoveries into life-saving patient treatments.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

Responding to geopolitical risks, Telenor is launching a new company to provide a secure, nationally controlled cloud for Norway's most sensitive data.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Germany's startups attracted €1.7B in Q1 2026, fueled by US investors and a massive bet on artificial intelligence, signaling a new era for its ecosystem.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.